Posters –
Devices and Imaging
NAME OF THE PROJECT
NAME OF THE MAIN CONTACT
ORGANISATION NAME
FIBIR
François-Xavier DENIMAL
SATT Nord
Detection and classification of liver fibrosis from serum by infrared spectroscopy
Detection method, gradation (F0-F4) and monitoring of liver fibrosis from serum.
Allows the identification of patients with a risk of hepatocellular carcinoma.
Technology
Infrared spectroscopy coupled with a specific statistical evaluation based on the content
of the spectral information obtained from the serum sample.
Method validated on more than 100 patients
Quick and easy to implement: in serum
Non-invasive: no use of biopsy
Repeatable: no intra or inter operator variability
Analysis of all the spectral characteristics
Customers / Target market
Industry and competitors
Financing need / Commercial
opportunity
IP – Patent situation
Future steps / Milestones
All the Hospital laboratories or private laboratories
Companies specialized in manufacturing of IVD Devices
We are looking for a partner in capacity to develop the product, obtain the CE Mark
and/or FDA agreement, market the product and assume the distribution worldwide.
2010 EP 10 757 603
"Serum infrared spectroscopy for non invasive assessment of hepatic fibrosis in patients
with chronic liver disease"
Production of the device on the base of the prototype and CE Marking
This project is the result of collaboration between two teams:
Further reading
One has a worldwide recognition for its work in biophotonics and technology for health,
has signed international partnerships, has participated in many research projects and has
developed lots of collaborations with the pharmaceutical industry.
The other team is specialized in the screening, diagnosis and treatment of diseases of the
gastrointestinal tract, pancreas and liver including digestive cancers. She is heavily
involved in translational research between research and clinic.
Contact person
Mr DENIMAL François-Xavier Pharm. D.
SATT Nord, Business Developer
francois-xavier.denimal@sattnord.fr